Parallel-group controlled trial of surgery versus chemoradiotherapy in patients with stage I esophageal squamous cell carcinoma

Posted on August 10, 2021 by Gastroenterology Journal

Surgery is the standard of care for T1bN0M0 esophageal squamous cell carcinoma (ESCC), while chemoradiotherapy (CRT) is a treatment option. This trial aimed to investigate the non-inferiority of CRT relative to surgery for T1bN0M0 ESCC.

This entry was posted in News. Bookmark the permalink.